These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17901882

  • 1. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.
    Wu TT, Wang HH.
    Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882
    [Abstract] [Full Text] [Related]

  • 2. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
    Dotan A, Kaiserman I, Kremer I, Ehrlich R, Bahar I.
    Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
    [Abstract] [Full Text] [Related]

  • 3. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N, Ozer A, Topbas S, Yildirim N, Yurdakul S.
    Ophthalmic Surg Lasers Imaging; 2003 Feb; 34(6):451-6. PubMed ID: 14620747
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K, Greite JH, Bartenschlager EM.
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [Abstract] [Full Text] [Related]

  • 5. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F, Boehnke M.
    Ger J Ophthalmol; 1992 Mar; 1(5):354-60. PubMed ID: 1477641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sonothrombolysis for intraocular fibrin formation in an animal model.
    Yamashita T, Ohtsuka H, Arimura N, Sonoda S, Kato C, Ushimaru K, Hara N, Tachibana K, Sakamoto T.
    Ultrasound Med Biol; 2009 Nov; 35(11):1845-53. PubMed ID: 19699025
    [Abstract] [Full Text] [Related]

  • 12. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
    Heiligenhaus A, Steinmetz B, Lapuente R, Krallmann P, Althaus C, Steinkamp WK, Dick B.
    Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Vitreous hemorrhage after vitrectomy in diabetic retinopathy and tissue plasminogen activator].
    Asensio Sánchez VM, Pérez Flández FJ, Carlos Bejarano J, Fernández Concellón L.
    Arch Soc Esp Oftalmol; 2002 Jan; 77(1):7-12. PubMed ID: 11813114
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal r-TPA and gas injection in traumatic submacular hemorrhage.
    Holland D, Wiechens B.
    Ophthalmologica; 2004 Jan; 218(1):64-9. PubMed ID: 14688438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.